TRI COLLABORATORS

Richard Catalano, Ph.D. is a member of the Scientific Advisory Board to the TRI Parents Translational Research Center.  Bartley Dobb Professor for the Study and Prevention of Violence and Director of the Social Development Research Group, School of Social Work, and adjunct professor of Education and Sociology at the University of Washington, Dr. Catalano's work has focused on discovering risk and protective factors for positive and problem behavior in youth and designing and evaluating prevention programs to address these factors.

Doreen Cavanaugh, Ph.D. is a Research Associate Professor at the Health Policy Institute, Georgetown Public Policy Institute, Georgetown University where she is responsible for a program of research and policy analysis in the areas of child and adolescent mental health and substance abuse treatment.  Her many accomplishments include National Program Director of a 16 state CSAT grant initiative to improve delivery of treatment for adolescents with substance use and co-occurring disorders.  Dr. Cavanaugh's work addresses the financing, organization and quality of treatment and recovery services for youth with substance use or mental health disorders. Currently she is collaborating on a number of initiatives supporting the implementation of the Patient Protection and Affordable Care Act. Dr. Cavanaugh is a member of the Scientific Advisory Board to the Parents’ Translational Research Center at TRI. 

Ronald E. Dahl, M.D. is a pediatrician and Professor, Community Health and Human Development & Joint Medical Program in the School of Public Health UC Berkeley, is a member of the Scientific Advisory Board to the Parents’ Translational Research Center at TRI.  His research focuses on neuro-maturational changes at puberty and more broadly the developmental period of adolescence as a time of unique opportunities for early intervention in relation to a wide range of behavioral and emotional health problems.
 
Gayle Dakof, Ph.D is a clinical psychologist licensed in two States. She is a Research Associate Professor in the Department of Epidemiology and Public Health at the University of Miami, and also is the Director of MDFT International, a non-profit organization devoted to training counselors and community based organizations in Multidimensional Family Therapy.  A member of the Scientific Advisory Board to the Parents Translational Research Center at TRI, Dr. Dakof's research interests include testing the effectiveness of MDFT, family-based interventions within the dependency drug court context, and adaptation and adoption of empirically-supported adolescent treatment in community settings.

Richard Dembo, Ph.D. is a Professor in the Department of Criminology at the University of South Florida.  Collaborating with TRI on several studies to improve prospects for offender youth, Dr. Dembo’s research interests include interventions for high-risk youth and issues in juvenile justice and juvenile delinquency.

Department of Psychiatry, University of Minnesota Medical School: Ken C. Winters, Ph.D. is Professor in this University as well as Principal Investigator of several NIDA-funded research studies on prevention and treatment of adolescent substance abuse. Dr. Winters is a Senior Scientist at TRI and Associate Director of the Parents’ Translational Research Center.

Drug Strategies is a non-profit research institute based in Washington, D.C. that identifies and promotes more effective approaches to drug abuse prevention and treatment. Mathea Falco, founder and President of Drug Strategies, is a principal collaborator with TRI on projects related to adolescent drug treatment, including A Parents Guide to Adolescent Treatment and the availability of drugs on the Internet.

Marc Fishman, M.D. is a member of the Scientific Advisory Board to the Parents’ Translational Research Center at TRI.  Dr. Fishman is an addiction psychiatrist, faculty member at the Johns Hopkins School of Medicine, and co-editor of the ASAM Patient Placement Criteria (ASAM PPC2-R). As the head of the Mountain Manor Treatment Center in Baltimore, he has extensive experience in the treatment of substance using and dually diagnosed adolescents and their families. He is Chair of the Adolescent Committee of the American Society of Addiction Medicine (ASAM), and serves as a member of the Steering Committee of the NIDA Clinical Trials Network (CTN) representing the Mid-Atlantic Node. He is currently serving a term as the President of the Maryland Society of Addiction Medicine.

Michael French, Ph.D. is a Professor in the Departments of Sociology, Economics, Epidemiology and Public Health at the University of Miami and is Director of its Health Economics Group.  Dr. French collaborates on TRI research projects, adding cost-benefit and other financial study components.  He has also presented on cost and financing issues to the Mutual Assistance Program for the States.

David P. Friedman, Ph.D. is a neuroscientist who studies addiction.  He is a professor in the Department of Physiology and Pharmacology and the Associate Dean for Research at the Wake Forest University School of Medicine.  TRI is a collaborator on the NIDA-funded Addiction Studies Program (ASP) for the States, a project directed by Dr. Friedman to provide science-based educational material to legislators and Executive branch policy makers at the State level.

Next page >>